103 related articles for article (PubMed ID: 1649511)
1. RU486 inhibits glucocorticoid hormone-dependent oncogenesis by human papillomavirus type 16 DNA.
Pater MM; Pater A
Virology; 1991 Aug; 183(2):799-802. PubMed ID: 1649511
[TBL] [Abstract][Full Text] [Related]
2. Glucocorticoid requirement for growth of human papillomavirus 16-transformed primary rat kidney epithelial cells: correlation of development of hormone resistance with viral RNA expression and processing.
Pater A; Belaguli NS; Pater MM
Cancer Res; 1993 Sep; 53(18):4432-6. PubMed ID: 8395983
[TBL] [Abstract][Full Text] [Related]
3. Glucocorticoid-dependent oncogenic transformation by type 16 but not type 11 human papilloma virus DNA.
Pater MM; Hughes GA; Hyslop DE; Nakshatri H; Pater A
Nature; 1988 Oct; 335(6193):832-5. PubMed ID: 2847052
[TBL] [Abstract][Full Text] [Related]
4. RU486 increases radiosensitivity and restores apoptosis through modulation of HPV E6/E7 in dexamethasone-treated cervical carcinoma cells.
Kamradt MC; Mohideen N; Vaughan AT
Gynecol Oncol; 2000 Apr; 77(1):177-82. PubMed ID: 10739708
[TBL] [Abstract][Full Text] [Related]
5. Differential cooperation of a carcinogen with human papillomavirus type 6 and 16 DNAs in in vitro oncogenic transformation.
Mitrani-Rosenbaum S; Tsvieli R
Intervirology; 1992; 33(2):76-85. PubMed ID: 1314784
[TBL] [Abstract][Full Text] [Related]
6. Transformation of primary BRK cells by human papillomavirus type 16 and EJ-ras is increased by overexpression of the viral E2 protein.
Lees E; Osborn K; Banks L; Crawford L
J Gen Virol; 1990 Jan; 71 ( Pt 1)():183-93. PubMed ID: 2154535
[TBL] [Abstract][Full Text] [Related]
7. Glucocorticoid-dependent transformation by human papillomavirus type 16 E7 coding and 3' noncoding sequences.
Pater A; Belaguli NS; Gardner HA; Mithal A; Pater MM
Virology; 1992 May; 188(1):369-72. PubMed ID: 1314461
[TBL] [Abstract][Full Text] [Related]
8. Retinoic acid suppresses human papillomavirus type 16 (HPV16)-mediated transformation of human keratinocytes and inhibits the expression of the HPV16 oncogenes.
Creek KE; Jenkins GR; Khan MA; Batova A; Hodam JR; Tolleson WH; Pirisi L
Adv Exp Med Biol; 1994; 354():19-35. PubMed ID: 8067286
[TBL] [Abstract][Full Text] [Related]
9. Glucocorticoids stimulate growth of human papillomavirus type 16 (HPV16)-immortalized human keratinocytes and support HPV16-mediated immortalization without affecting the levels of HPV16 E6/E7 mRNA.
Khan MA; Canhoto AJ; Housley PR; Creek KE; Pirisi L
Exp Cell Res; 1997 Oct; 236(1):304-10. PubMed ID: 9344611
[TBL] [Abstract][Full Text] [Related]
10. Amplification and overexpression of c-myc proto-oncogene correlate with the loss of glucocorticoid dependence in rodent cells transformed by human papillomavirus type 16.
Crook T; Banks L; Smith K; Crawford L
Mol Carcinog; 1989; 2(6):308-13. PubMed ID: 2482744
[TBL] [Abstract][Full Text] [Related]
11. Up-regulation of hormone response of human papillomavirus type 16 expression and increased DNA-protein binding by consensus mutations of viral glucocorticoid response elements.
Khare S; Kumar KU; Tang SC; Pater MM; Pater A
J Med Virol; 1996 Nov; 50(3):254-62. PubMed ID: 8923291
[TBL] [Abstract][Full Text] [Related]
12. Constitutive expression of c-myc oncogene confers hormone independence and enhanced growth-factor responsiveness on cells transformed by human papilloma virus type 16.
Crook T; Almond N; Murray A; Stanley M; Crawford L
Proc Natl Acad Sci U S A; 1989 Aug; 86(15):5713-7. PubMed ID: 2548186
[TBL] [Abstract][Full Text] [Related]
13. Human papillomavirus type 16 cooperates with activated ras and fos oncogenes in the hormone-dependent transformation of primary mouse cells.
Crook T; Storey A; Almond N; Osborn K; Crawford L
Proc Natl Acad Sci U S A; 1988 Dec; 85(23):8820-4. PubMed ID: 2848240
[TBL] [Abstract][Full Text] [Related]
14. Biological and biochemical activity of E7 genes of the cutaneous human papillomavirus type 5 and 8.
Yamashita T; Segawa K; Fujinaga Y; Nishikawa T; Fujinaga K
Oncogene; 1993 Sep; 8(9):2433-41. PubMed ID: 8395681
[TBL] [Abstract][Full Text] [Related]
15. Transforming activity of the E6 gene of HPV-11gt in NIH 3T3 and REF 52 cells: correlation with the level of E6 transcription.
Trujillo JM; Mounts P
Virology; 1996 Jun; 220(1):1-9. PubMed ID: 8659100
[TBL] [Abstract][Full Text] [Related]
16. The expression levels of the human papillomavirus type 16 E7 correlate with its transforming potential.
Liu Z; Ghai J; Ostrow RS; Faras AJ
Virology; 1995 Feb; 207(1):260-70. PubMed ID: 7871737
[TBL] [Abstract][Full Text] [Related]
17. Retinoic acid inhibition of human papillomavirus type 16-mediated transformation of human keratinocytes.
Khan MA; Jenkins GR; Tolleson WH; Creek KE; Pirisi L
Cancer Res; 1993 Feb; 53(4):905-9. PubMed ID: 8381332
[TBL] [Abstract][Full Text] [Related]
18. Glucocorticoid-enhanced neoplastic transformation of human keratinocytes by human papillomavirus type 16 and an activated ras oncogene.
Dürst M; Gallahan D; Jay G; Rhim JS
Virology; 1989 Dec; 173(2):767-71. PubMed ID: 2556855
[TBL] [Abstract][Full Text] [Related]
19. Co-transformation by human papillomavirus types 6 and 11.
Storey A; Osborn K; Crawford L
J Gen Virol; 1990 Jan; 71 ( Pt 1)():165-71. PubMed ID: 2154533
[TBL] [Abstract][Full Text] [Related]
20. Human papillomavirus type 6b DNA required for initiation but not maintenance of transformation of C127 mouse cells.
Morgan D; Pecoraro G; Rosenberg I; Defendi V
J Virol; 1990 Mar; 64(3):969-76. PubMed ID: 2154622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
